Buy or sell ZappRx stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
ZappRx Stock
Prescription & Prior Authorization Platform
About ZappRx Stock
ZappRx is a digital health company that is modernizing and simplifying the way specialty drugs are managed. We provide a secure, collaborative online platform that allows patients, physicians, and pharmacists to work together to improve patients’ access to treatment and deliver medicine faster.
Investors
Funding History
| September 2013 | $1.0M |
|---|---|
| January 2014 | $1.0M |
| April 2015 | $14.0M |
| April 2017 | $25.0M |
Management
Founder & CEO
Zoe Barry
Chief Operating Officer
Sandy DiCesare
Press
Business Wire (press release) - Nov, 28 2017
Business Wire (press release) - Nov, 21 2017
Lung Disease News - Jul, 25 2017
PR Newswire (press release) - Jul, 20 2017
TechCrunch - Apr, 20 2017
EquityZen does not have an affiliation with, formal relationship with, or endorsement from any companies featured above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
